| Revenues | 3.68M |
| Reimbursement revenues | 172.67K |
| Total revenues | 3.86M |
| Cost of services | 2.07M |
| Cost of reimbursement revenues | 172.67K |
| Total cost of services | 2.24M |
| Gross profit | 1.62M |
| Research and development | 306.27K |
| Sales and marketing | 269.8K |
| General and administrative | 1.42M |
| Depreciation and amortization | 104.93K |
| Total operating expenses | 2.1M |
| Operating income | -481.6K |
| Other income | 53 |
| Other expense | -156 |
| Gain (Loss) on derivative financial instrument | |
| Total other income (expense) | -23.56K |
| Net income | -505.16K |
| Series B preferred stock dividend | 42K |
| Net income attributable to common stockholders | -547.16K |
| Weighted average basic shares outstanding (in shares) | |
| Weighted average diluted shares outstanding (in shares) | |
| Basic and diluted earnings per share (in dollars per share) | -0.18 |